{"filing":{"accession_number":"0001794546-26-000015","cik":"0001794546","ticker":"CARL","company_name":"CARLSMED, INC.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"carl-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1794546/000179454626000015/carl-20260805.htm"},"events":[{"id":25253,"run_id":22916,"accession_number":"0001794546-26-000015","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Carlsmed issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $18.9 million (57% YoY growth), gross margin expansion of 340 basis points, and raising full-year 2026 revenue guidance to $74–$78 million. The filing includes condensed statements of operations, balance sheets, and reconciliation tables, all hallmarks of a quarterly earnings release under Item 2.02.","company_name":"CARLSMED, INC.","ticker":"CARL","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":26031,"accession_number":"0001794546-26-000015","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Carlsmed issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $18.9 million (57% YoY growth), gross margin expansion of 340 basis points, and raising full-year 2026 revenue guidance to $74–$78 million. The filing includes condensed statements of operations, balance sheets, and reconciliation tables, all hallmarks of a quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:23:10.264220+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26031,"accession_number":"0001794546-26-000015","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Carlsmed issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $18.9 million (57% YoY growth), gross margin expansion of 340 basis points, and raising full-year 2026 revenue guidance to $74–$78 million. The filing includes condensed statements of operations, balance sheets, and reconciliation tables, all hallmarks of a quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:23:10.264220+00:00","company_name":"CARLSMED, INC.","ticker":"CARL","filing_date":"2026-08-05"}]}